Mouse IGFBP-2 PharmaGenie ELISA Kit (SBRS1400)

Insulin-like growth factor binding protein 2 (IGFBP-2) regulates IGF-1 and IGF-2 bioavailability and tissue distribution, which is why this secreted carrier protein is widely studied as a biomarker in cancer biology, metabolic disease models, and murine developmental research. The Assay Genie Mouse IGFBP-2 PharmaGenie ELISA Kit is built to quantify IGFBP-2 levels in samples obtained from mouse studies, supporting both cell culture supernatant analysis and blood-derived matrices.

The kit is supplied as a complete microplate-based assay in a 96-assay format that integrates with standard absorbance plate readers. Validated sample types include mouse serum samples, mouse plasma samples, and conditioned media from cultured cells, which lets the same kit handle in vitro work on treated cell lines and in vivo characterization of transgenic or knockout mouse cohorts. Each plate is processed through a standard incubation and wash workflow, producing a readout that reflects accumulated IGFBP-2 in the loaded sample.

Common applications include profiling IGFBP-2 secretion in tumor cell line studies, tracking circulating protein levels in diet-induced obesity and type 2 diabetes models, and quantifying expression changes across tissues during mouse development. The mouse-specific reactivity matters when working with species-specific phenotypes, because off-species cross-reactivity would confound interpretation of the IGF signaling axis. The kit format also supports batched cohort analysis for longitudinal studies where multiple time points or treatment groups are compared within a single run.